Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toll-like receptor 4 or 2 agonists decrease allergic inflammation.

German Velasco1, Monica Campo, Oscar J Manrique

  • 1Respiratory and Critical Care Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

American Journal of Respiratory Cell and Molecular Biology
|December 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registry.

The Journal of investigative dermatology·2026
Same author

Direct impure water electrolysis at industrial scale.

Chemical Society reviews·2026
Same author

Post-pandemic resurgence of Mycoplasma pneumoniae and its emerging link with Rhinovirus in children.

Infection·2026
Same author

Early neutrophil and persistent eosinophil-associated gene signature in childhood asthma.

American journal of respiratory and critical care medicine·2026
Same author

Correction: Severe Asthma in Children and Adolescents: an AWMF Guideline by the German Society for Pediatric Pulmonology.

Klinische Padiatrie·2026
Same author

Artificial Intelligence-powered tiered early warning framework addressing high false alarm rates for in-hospital mortality prediction.

NPJ digital medicine·2026

Stimulating Toll-like receptors (TLRs) with bacterial components like lipid A and peptidoglycan can reduce allergic inflammation. This suggests bacterial exposure may protect against allergic diseases.

Area of Science:

  • Immunology
  • Allergy Research
  • Microbiology

Background:

  • Toll-like receptors (TLRs) are key in recognizing microbial patterns.
  • TLR4 and TLR2 are involved in innate immune responses.
  • Allergic inflammation involves adaptive immune responses.

Purpose of the Study:

  • To investigate if TLR4 and TLR2 stimulation modulates allergic immune responses.
  • To analyze the effects of TLR agonists on allergic inflammation in a murine model.

Main Methods:

  • Pulmonary administration of TLR4 agonist (lipid A) and TLR2 agonists (peptidoglycan, PamCys) in mice.
  • TLR agonists administered during allergen sensitization or challenge.
  • Analysis of inflammatory markers including eosinophils, IL-13, IgE, and CD4+ cells.

Related Experiment Videos

Main Results:

  • TLR agonists decreased allergen-induced eosinophil recruitment.
  • Administration before sensitization reduced pulmonary eosinophilia, IL-13, IgE, and airway hyperresponsiveness.
  • TLR agonists reduced CD4+ cells in the lung and lymphocyte proliferation in lymph nodes.

Conclusions:

  • TLR4 and TLR2 stimulation can decrease adaptive allergic responses.
  • Non-antigen-dependent stimuli modulate allergic immunity.
  • Bacterial component exposure may offer protection against allergic disease.